| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $5.4B | $4.9B | $5.2B | $4.6B | $1.4B | $1.1B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $0.9B | $0.7B | $0.6B |
| Operating Income | $0.8B | $1.3B | $0.7B | $1.3B | $1.2B | $0.5B | $0.3B | $0.3B |
| Net Income | $0.1B | $0.7B | $0.3B | $1.0B | $0.8B | $0.4B | $0.1B | $0.2B |
| EPS (Basic) | $3.04 | $21.73 | $9.78 | $24.68 | $19.81 | $8.32 | $2.46 | $3.36 |
| EPS (Diluted) | $3.00 | $21.41 | $9.64 | $24.16 | $18.98 | $7.97 | $2.36 | $3.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.8B | $11.5B | $12.1B | $12.7B | $13.3B | $13.4B | $14.0B | $7.1B |
| Current Assets | $1.5B | $1.3B | $1.5B | $1.6B | $1.4B | $1.2B | $1.4B | $0.8B |
| Cash & Equivalents | $0.3B | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $8.8B | $9.2B | $9.8B | $9.9B | $10.4B | $10.9B | $11.9B | $5.2B |
| Current Liabilities | $0.7B | $0.8B | $1.0B | $0.9B | $0.8B | $0.7B | $0.9B | $0.4B |
| Stockholders' Equity | $2.1B | $2.3B | $2.3B | $2.7B | $2.9B | $2.5B | $2.0B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $1.3B | $1.0B | $1.4B | $1.2B | $1.3B | $0.4B | $0.7B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.2B | $0.1B | $-0.2B | $-0.0B | $-4.7B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.6B | $-1.2B | $-0.9B | $-1.5B | $-0.9B | $-1.3B | $4.4B | $-0.5B |